Gilbert Omenn and his syndrome by Ahmad Al Aboud & Khalid Al Aboud
  55 
 
 
 
GILBERT OMENN AND HIS SYNDROME 
GILBERT OMENN I OPISANY PRZEZ NIEGO ZESPÓŁ CHOROBOWY 
 
Ahmad Al Aboud
1 Khalid Al Aboud
2 
 
1Dermatology Department, King Abdullah Medical City, Makkah, Saudi Arabia 
2Dermatology Department, King Faisal Hospital, Makkah, Saudi Arabia 
 
            Corresponding author: Dr. Khalid Al Aboud       amoa65@hotmail.com 
 
Our Dermatol Online. 2012; 3(1): 55-56                                   Date of submission: 22.10.2011 / acceptance: 18.11.2011 
                                                                                                                                            Conflicts of interest: None 
 
Abstract 
Gilbert Omenn is  a well-known American Geneticist. In the 1965, He reported a rare genetic disorder  —later known as Omenn 
syndrome. This syndrome is a variant of severe combined immunodeficiency which is associated with hypereosinophilia. It is one of the 
differential diagnoses of neonatal erythroderma. 
This concise report sheds light on Gilbert Omenn and the syndrome that bears his name. 
 
Streszczenie 
Gilbert  Omenn  jest  znanym  amerykańskim  genetykiem.  W  1965  r.  opisał  rzadką  genetyczną  chorobę,  znaną  później  jako  zespół 
Omenna. Ten zespół jest wariantem cięŜkiego, złoŜonego niedoboru odporności, związanego z eozynofilią. Jest jednym z rozpoznań 
róŜnicowych noworodków erytrodermii. 
Ten zwięzły raport rzuca światło na Gilberta Omenna i zespół chorobowy, który nosi jego imię 
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Introduction 
Gilbert Omenn (Fig. 1) is currently, a Director 
of  Center  for  Computational  Medicine  and 
Bioinformatics  and  Professor  of  Internal  Medicine, 
Human  Genetics,  &  Public  Health,  at  University  of 
Michigan, Ann Arbor, MI, USA [1]. 
He  is  a  world-renowned  geneticist.  Among  his  great 
medical  contributions,  he  is  credited  for  describing  a 
reticuloendotheliosis  with  eosinophilia  in  several 
individuals in related sibships from an inbred American 
family  of  Irish  extraction  [2],  later  known  as  Omenn 
syndrome (OS) [3-6]. 
 
Omenn syndrome 
OS  (OMIM  #603554)  is  a  rare  autosomal 
recessive  genetic  disorder  and  presents  symptoms  of 
severe  combined  immunodeficiency  (SCID).  It  is 
characterized  by  erythrodermia,  eosinophilia, 
hepatosplenomegaly,  lymphadenopathy,  alopecia  and 
elevated serum IgE levels. 
Similar  to  other  patients  with  SCID,  patients  with  OS 
present early in infancy with viral or fungal pneumonitis, 
chronic  diarrhea,  and  failure  to  thrive.  Unlike  typical 
SCID, patients with OS have enlarged lymphoid tissue, 
severe  erythroderma,  increased  IgE  levels,  and 
eosinophilia [5]. 
         
         Figure 1. Gilbert Omenn 
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OS is also known as Reticuloendotheliosis, familial with 
eosinophilia,  and  also  known  as  severe  combined 
immunodeficiency with hypereosinophilia [3]. 
The  syndrome  is  reported  from  different  places  in  the 
world  but  large  series  of  patients  were  reported  from 
Middle East. 
Some authors [6] performed literature search, for Omenn 
syndrome,  using  Medline,  encompassing  the  period 
1965-1999.  They  collected  68  cases  and  they  founded 
that median age at onset of symptoms, in this disorder, 
was  4  weeks.  Key  symptoms  were  erythematous  rash 
(98%),  hepatosplenomegaly  (88%),  and 
lymphadenopathy  (80%),  often  accompanied  by 
recurrent  infections  (72%)  and  alopecia  (57%).  An 
elevated  WBC  (55%)  was  frequently  observed,  due  to 
eosinophilia  and/or  lymphocytosis.  B-cell  counts  were 
significantly  decreased  whereas  T-cell  counts  were 
elevated. A high serum IgE was another frequent finding 
(91%).  Therapeutic  options,  which  were  used  in  the 
reviewed patients, include bone marrow transplantation 
or  cord  blood  stem  cell  transplantation;  however,  the 
mortality was 46%. The authors concluded that, Omenn 
syndrome is a fatal disease if untreated. They believed 
that,  the  mortality  may  be  reduced  when  diagnosis  is 
established  early  and  treatment  is  initiated  rapidly  by 
using  early  compatible  bone  marrow transplantation or 
cord blood stem cell transplantation [6]. 
The  syndrome  can  be  caused  by  mutation  in  the 
recombination  activating  genes  (RAG1  and  RAG2) 
genes  on  chromosome  11p  and  the  Artemis  gene 
(DCLRE1C) on chromosome 10p [3].  
In this disorder, there is a peculiar severe T-cell immune 
deficiency  associated  with  autoimmunelike 
manifestations.  Dysregulations  of  the  central  and 
peripheral  immune  tolerance,  mediated  by  the  protein 
autoimmune  regulator  (AIRE)  and  regulatory  T  cells, 
respectively, were proposed as possible mechanisms of 
this aberrant inflammatory process.  
Erythroderma  is  one  of  the  main  features  of  this 
syndrome.  The  rash  may  be  present at birth or evolve 
over  the  first  few  weeks  of  life.  There  is  also 
lymphadenopathy,  particularly  of  the  axillary  and 
inguinal  nodes,  as  well  as  increased  serum  IgE  levels 
with  a  marked  eosinophilia  and  combined 
immunodeficiency [4]. Children usually present in early 
infancy but atypical forms may present later in the first 
year of life. Children usually suffer diarrhea, failure to 
thrive and persistent infection, as seen in other forms of 
SCID [4].  
The  clinical  picture  may  resemble  SCID  with 
maternofetal engraftment, when maternal T lymphocytes 
crossing the placenta cause a graft-versus-host disease-
like reaction in an immunoincompetent patient [4].  
Histology of the skin shows a dense, dermal perivascular 
lymphohistiocytic  infiltrate,  comprising  activated  T 
lymphocytes,  with numerous eosinophils. S100-staining 
Langerhans'  cells  are  usually  absent,  and  there  is  no 
epidermotropism.  
In the older literature this condition has been confused 
with  Langerhans'  cell  histiocytosis  (Letterer–Siwe 
disease) [4]. 
It is proved that both HLA-identical and haploidentical 
allogenic  bone  marrow  transplant  (BMT)  can  cure 
Omenn syndrome, provided that parenteral nutrition and 
immunosuppressive  therapy  are  given  before 
transplantation [3]. 
 
Gilbert Omenn 
Gilbert  Omenn  was  born  30-Aug-1941,  in 
Chester, PA, USA. He received his education and served 
in  several  institutes  in  USA.  He  describes  Omenn 
syndrome while he was a medical student in Harvard. 
Gilbert Omenn published more than 400 papers and he 
authored  and  edited  more  than  15  books.  He  holds 
various  scientific  assignments  inside  and outside USA. 
He  is  active  in  many  cultural  and  educational 
organizations. He has won several honors and awards. 
This  short  report  can  not  encompass  his  impressive 
career  which  can  be  read  online  in  many  internet 
websites  [1].  Music  and  Tennis  is  among  Dr  Omenn 
extra scientific interests. 
His  research  interests  include  clinical  informatics, 
databases  and  computing,  medical  and  translational 
research, and proteomics [1].
      
Dr. Omenn's research focuses on cancer proteomics and 
informatics. He leads the Proteomics Alliance for Cancer 
Research,  the  HUPO  Plasma  Proteome  Project,  the 
Driving Biological Problems Core of the National Center 
for  Integrative  Biomedical  Informatics,  and  the  Center 
for Computational Medicine and Bioinformatics [1].  
He has long-standing interests in mechanisms of genetic 
predispositions  to  risks  from  environmental  and 
occupational  exposures,  pharmacogenetics  and 
pharmacogenomics, and science-based risk analyses [1]. 
He was, also, the principal investigator for many years of 
the Beta-Carotene and Retinol Efficacy Trial (CARET) 
for chemoprevention of lung cancers and heart disease. 
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